biomedicina slovenica

"Clopidogrel" : 56

  1. Orban Martin; Kleeberger Jan; Ouarrak Taoufik; Freund Anne; Feistritzer Hans-Josef; Fuernau Georg; Geisler Tobias; Huber Kurt; Dudek Dariusz; Noč Marko
    Clopidogrel vs. prasugrel vs. ticagrelor in patients with acute myocardial infarction complicated by cardiogenic shock
    2021 ►
  2. Rojko Maja; Černič Šuligoj Nataša; Cvetičanin Branko; Zorc Marjeta; Mendiz Oscar; Noč Marko
    Tromboza lističev perkutano vstavljene aortne zaklopke
    [Leaflet thrombosis after transcatheter aortic valve implantation]
    2019 ►
  3. Huber Kurt; Ducrocq Gregory; Hamm Christian W.; Hof Arnoud van 't; Lapostolle Frederic; Coste Pierre; Gordini Giovanni; Steinmetz Jacob; Verheugt Freek; Adgey Jennifer; Kanič Vojko
    Early clinical outcomes as a function of use of newer oral P2Y [sub] 12 inhibitors versus clopidogrel in the EUROMAX trial
    2017 ►
  4. Steblovnik Klemen; Blinc Aleš; Božič Mojca; Fister Miša; Mikuž Urša; Noč Marko
    Ticagrelor versus clopidogrel in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and hypothermia
    2016 ►
  5. Kanič Vojko; Lobnik Anton
    Antitrombocitno zdravljenje po perkutanih posegih na srcu
    2007 ►
  6. Sinkovič Andreja; Piko Nejc; Privšek Matevž; Markota Andrej
    Gender-related differences in patients with ST-elevation myocardial infarction
    2015 ►
  7. Poredoš Pavel; Ježovnik Mateja; Kalodiki E.; Andreozzi G.M.; Antignani Pier Luigi; Clement D.L.; Fareed Jawed; Fras Zlatko; Fletcher Jonathan A.; Griffin S. Michael
    Medical management of patients with peripheral arterial disease
    2015 ►
  8. Zupančič Vinko; Smrkolj Matej; Benkič Primož; Simonič Igor; Ritlop Gregor; Kristl Albin; Vrečer Franc
    Characterization of different clopidogrel addition salts
    2008 ►
  9. Poredoš Pavel; Ježovnik Mateja
    Is aspirin still the drug of choice for management of patients with peripheralarterial disease?
    2013 ►
  10. Fuerst Jurij
    Preprečevanje bolezni z zdravili - prihranek ali strošek?
    [Prevention of diseases with drugs - savings or costs?]
    2012 ►
  11. Lipnik-Štangelj Metoda
    Assessment report for clopidogrel Mylan Pharma: international nonproprietary name: clopidogrel: procedure no. EMEA/H/C/001189
    2009 ►
  12. Lipnik-Štangelj Metoda
    Assessment report for Clopidogrel Teva: international nonproprietary name: clopidogrel: procedure no. EMEA/H/C/001053
    2009 ►
  13. Lipnik-Štangelj Metoda
    Assessment report for Grepid: international nonproprietary name: clopidogrel: procedure no. EMEA/H/C/001059
    2009 ►
  14. Skok Pavel; Ćeranić Davorin
    Zaviralci protonske črpalke in antiagregacijska zdravila
    [Proton pump inhibitors and antiplatelet therapy]
    2010 ►
  15. Poredoš P; Ježovnik MK
    Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease
    2010 ►
  16. Sinkovič Andreja
    Bolnik z akutnim miokardnim infarktom - ukrepi ob akutnem dogodku in ukrepanje v bolnišnici
    2010 ►
  17. Ho Michael P; Maddox Thomas M; Wang Li; Fihn Stephan D; Jesse Robert L; Peterson Eric D; Rumsfeld John S
    Tveganje za neželene izide, povezane s hkratno uporabo klopidogrela in inhibitorjev protonske črpalke po akutnem koronarnem sindromu
    [Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome]
    2009 ►
  18. Poredoš Pavel
    Low-dose aspirin for PAD patients
    2009 ►
  19. Dobovšek Darja; Butenko Tita; Zupan Igor
    Pojavnost glavnih srčno-žilnih dogodkov po vstavitvi navadnih opornic in opornic z zdravili
    [Incidence of major adverse cardiac events after bare metal and drug eluting stent implantation]
    2009 ►
  20. Petek-Šter Marija; Cedilnik-Gorup Eva; Klančič Dean
    Polifarmacija in neprimerno predpisovanje zdravil pri starostnikih v domovih starejših občanov
    [Polypharmacy and inappropriate drug prescribing in elderly nursing home residents]
    2009 ►
  21. Dobovšek D; Butenko T; Zupan Igor
    The incidence of mace after discontinuation of clopidogrel in patients with implanted drug eluting stent
    2008 ►
  22. Žvan Bojana
    Protiagregacijska zdravila v sekundarni preventivi ishemičnega možganskožilnega dogodka. Slovenska priporočila
    [Antiplatelet drugs in secondary prevention of cerebral ischemic event. Slovenian recommendations]
    2007 ►
  23. Černe Andreja; Bajc Barbara; Kokalj Anja; Kranjec Igor; Bunc Matjaž
    Učinkovitost antiagregacijskega zdravljenja po perkutani koronarni intervenci pri bolnikih s stabilno angino pektoris
    [Efficacy of antiplatelet therapy in patients with stable angina pectoris undergoing percutaneous coronary interventions]
    2007 ►
  24. Buić-Rerečić Dajna; Škufca Mateja; Zelinka Marko
    Zgodnja zunajbolnišnična uporaba klopidogrela pri akutnem koronarnem sindromu - varno in potrebno?
    [Early pre-hospital application of clopidogrel in ACS - is it safe and necessary?]
    2007 ►
  25. Klokočovnik Tomislav; Kržišnik-Zorman Simona; Weiss Miha
    Uspešno zdravljenje disekcije aorte tipa A z rekonstrukcijo aortne zaklopke po Tirone-Davidu pri bolniku z dvotirno antiagregacijsko zaščito. Prikaz primera
    [Successful treatment of aortic dissection type A with reconstruction of aortic valve according to Tirone-David in patient who received two-tier antiplatelet therapy. Case report]
    2007 ►
  26. Blinc A; Poredoš P
    Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease
    2007 ►
  27. Perme Rok; Blinc Aleš
    Neodzivnost na peroralno antiagregacijsko zdravljenje
    [Non-responsiveness to oral antiplatelet treatment]
    2006 ►
  28. Godec Manca; Sinkovič Andreja
    Gastrointestinal bleeding after primary percutaneous coronary intervention in acute coronary syndrome with ST-elevation on electrocardiogram - case report and review of literature
    [Krvavitev iz prebavil po primarni perkutani koronarni intervenciji zaradi akutnega koronarnega sindroma z elevacijo ST segmenta v elektrokardiogramu - prikaz primera in pregled literature]
    2006 ►
  29. Kržišnik-Zorman Simona; Radšel Peter; Noč Marko; Zorman Darko
    Subakutna tromboza v stentu
    [Subacute stent thrombosis]
    2006 ►
  30. Jug Borut; Šebeštjen Miran; Šabovič Mišo; Keber Irena
    Clopidogrel is associated with a lesser increase in NT-proBNP when compared to aspirin in patients with ischemic heart failure
    2006 ►
  31. Kržišnik-Zorman Simona; Klokočovnik Tomislav
    Zgodnje ali prezgodnje dajanje klopidogrela ob sumu na AKS
    [Clopidogrel for suspected ACS - early or too early?]
    2006 ►
  32. Starc Saša; Mihevc Nataša
    Antiagregacijska učinkovitost visokega odmerka klopidogrela pri kandidatih za perkutani koronarni poseg: določanje dele-a aktiviranih trombocitov z monoklonalnimi protitelesi za selektin-P
    [Effect of a high loading dose of clopidogrel on plateled inhibition in candidates for percutaneous coronary intervention: flow cytometric detection of activated platelets by monoclonal antibodies for P-selectine]
    2005 ►
  33. Starc Radovan; Starc Saša
    Rezistenca na klopidogrel in tveganje za nastanek subakutne tromboze v žilni opornici po perkutanem koronarnem posegu
    [Clopidogrel resistance and risk of subacute stent thrombosis after percutaneous coronary intervention]
    2005 ►
  34. Jug B; Ebetjen M; Keber I; Joras M
    Effect of aspirin vs. clopidogrel na NT-proBNP dynamics in patients with ischemic cardiomyopathy
    2005 ►
  35. Starc Saša; Mihevc Nataša
    Antiagregacijska učinkovitost visokega odmerka klopidogrela pri kandidatih za perkutani koronarni poseg: določanje deleža aktiviranih trombocitov z monoklonalnimi protitelesi za selektin-P
    2004 ►
  36. Bunc Matjaž; Kralj Jana; Brvar Miran; Šuput Dušan
    Platelet aggregation caused by poly-aps isolated from the marine sponge Reniera sarai could be only partly blocked by combination of acetyl salicilic acid, clopidogrel and eptifibatide
    2004 ►
  37. Bunc Matjaž
    Acetylsalicilic acid, clopidogrel and eptifibatide diminished in vivo lethality of i.v. application of poly-APS isolated from Reniera sarai
    2004 ►
  38. Šuput D; Bunc M
    Poly-APS induced thrombocyte aggregation is partly blocked by the combination of acetylsalicylic acid, clopidogrel and abciximab
    2003 ►
  39. Starc Radovan; Urbančič Jure; Starc Saša
    Akutni srčni infarkt zaradi trombotične zapore koronarne arterije pri zdravem rekreativnem športniku - angiografski prikaz
    [Acute myocardial infarction caused by thrombotic occlusion of coronary artery in a healthy recreational sportsman after a strenuous sport activity - angiographic presentation]
    2004 ►
  40. Gričar Marko
    Obravnava bolnikov z akutnim koronarnim sindromom brez elevacije veznice ST v bolnišnici
    [Hospital management of patient with acute coronary syndromes without ST-segment elevation]
    2004 ►
  41. Šarc Lucija
    Mehanizem letalnih učinkov poly APS, toksina izoliranega iz morske spužve Reniera sarai
    2003 ►
  42. Golob-Gulič Tatjana
    Farmakoekonomika klopidogrela
    [Pharmacoeconomic aspect of clopidogrel]
    2004 ►
  43. Kanič Vojko
    Klopidogrel in koronarna bolezen
    [Clopidogrel and coronary heart disease]
    2004 ►
  44. Zver Samo; Žontar Darja
    Določitev števila aktiviranih trombocitov s protitelesi za aktivirani fibrinogen in selektin-P pri bolnikih z esencialno trombocitemijo in vpliv antiagregacijskih zdravil
    [Definition of activated thrombocyte number with antibodies for activated fibrinogen and P-selectin in patients with essential thrombocythemia and antiaggregation drug effect]
    2004 ►
  45. Zver Samo
    Določitev števila aktiviranih trombocitov s protitelesi za aktivirani fibrinogen in selektin-P pri bolnikih z esencialno trombocitemijo in vpliv antiagregacijskih zdravil
    2003 ►
  46. Noč Marko
    Bolnik po perkutani koronarni angioplastiki - kaj mora vedeti zdravnik na terenu?
    [A patient after percutaneous coronary intervention - what every general practitioner should know?]
    2002 ►
  47. Ponikvar R; Buturovič-Ponikvar J
    The impact of antiaggregating drugs on native arteriovenous fistula survival: clopidogrel vs. aspirin
    2001 ►
  48. Grad Anton; Denišlič Miro
    Zdravljenje žilne demence
    [Therapy of vascular dementia]
    2001 ►
  49. Poredoš Pavel
    Klopidogrel - nova možnost preprečevanja srčno-žilnih zapletov
    [Clopidogrel - a new opportunity for preventing cardiovascular complications]
    2001 ►
  50. Grad Anton
    Antiagregacijsko zdravljenje bolnika z nevrološkim obolenjem s strani zdravnika družinske medicine
    [Antiplatelet therapy in family practice in patients with neurological disorders]
    2001 ►
  51. Kranjec Igor
    Perkutani koronarni revaskularizacijski posegi in antiagregacijsko zdravljenje - vodenje v ambulantah ZDM
    [Percutaneous coronary revascularization techniques and antiaggregational treatment - management in general practice]
    2001 ►
  52. Blinc Aleš
    Antiagregacijsko zdravljenje - indikacije, učinkovitost in zapleti
    [Antiplatelet therapy - indications, efficacy and complications]
    2001 ►
  53. Vodopivec-Jamšek Vlasta
    Antiagregacijsko zdravljenje v ambulanti družinskega zdravnika
    [Antiplatelet therapy in family practice]
    2001 ►
  54. Ponikvar R; Buturović-Ponikvar J
    The impact of antiaggregating drugs on native arteriovenous fistula survival: clopidogrel vs. aspirin
    2000 ►
  55. Ponikvar R; Buturović-Ponikvar J
    The impact of antiaggregating drugs on native arteriovenous fistula survival: clopidogrel vs. aspirin
    2000 ►
  56. Meglič Bernard
    Sodobno antiagregacijsko in antikoagulantno zdravljenje možganske kapi
    [Contemporary antiaggregation and anticoagulation stroke therapy]
    1999 ►


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics